Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Permira joins race for The Team as sports agency attracts buyout interest
Permira joins race for The Team as sports agency attracts buyout interest Permira is among several investors exploring a potential acquisition of The Team, the sports talent agency formerly known as Wasserman, according to a report by the New York Times. The firm...
Australian investors embark on UK–France tour to deploy $430bn into Europe
Australian investors embark on UK–France tour to deploy $430bn into Europe Australian superannuation funds are ramping up their focus on European private markets, with senior investors travelling to France and the UK to source new opportunities across infrastructure...
TA Associates eyes $810m takeover of UK-listed Advanced Medical Solutions
TA Associates eyes $810m takeover of UK-listed Advanced Medical Solutions TA Associates is in talks to acquire Advanced Medical Solutions in a potential $810m transaction, Reuters reported. The US-based private equity firm is preparing a possible offer of 280p per...